SLC6A3 and Parkinson disease: Consistently, in a recent study we also found similar striatal DAT binding ratios (SBRs) among N = 15 LRRK2-PD, N = 16 GBA1-PD, and N = 15 sPD early-stage patients with a mean disease duration of 2.6 years [26].